Company intelligence / Profile preview

SynapCell

Grenoble, Auvergne-Rhône-Alpes, Francesynapcell.com ↗

Ownership: Private
Development stage: Commercial

Overview

SynapCell provides advanced preclinical EEG-based CRO services specializing in central nervous system drug discovery. Their expertise lies in using translational rodent models and quantitative EEG biomarkers to predict efficacy of candidate drugs targeting epilepsy, movement disorders, psychiatric conditions and neurodegenerative diseases. They support decision-making from early discovery through lead selection by providing robust data on compound effects in vivo. The company has over two decades of experience with global biopharma clients and academic partners.

Therapeutic areas: PsychiatryNeurology
Modalities: Small moleculeBiologicDevice
Industry: Drug Discovery Services

Partnerships

University of Utah Anticonvulsant Drug Development Program/NIH NINDS Epilepsy Therapy Screening ProgramMajor pharmaceutical/biotech companies worldwide as CRO clients

Beyond the preview

Go deeper on SynapCell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SynapCell.

Explore the full profile